The conundrum of HLA-DRB1*14:01/*14:54 and HLA-DRB3*02: 01/*02:02 mismatches in unrelated hematopoietic SCT

Bone Marrow Transplantation

Volumn 46, Issue 7, 2011, Pages 916-922

  Pasi, A ^a   Crocchiolo, R ^b   Bontempelli, M ^c   Carcassi, C ^d   Carella, G ^e   Crespiatico, L ^f   Garbarino, L ^g   Mascaretti, L ^h   Mazzi, B ⁱ   Mazzola, G ^j   Miotti, V ^k   Porfirio, B ^l   Tagliaferri, C ^m   Valentini, T ⁿ   Vecchiato, C ^o   Fleischhauer, K ^i,p   Sacchi, N ^g   Bosi, A ^q   Martinetti, M ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c OSPEDALI RIUNITI   (Italy)

^d UNIVERSITY OF CAGLIARI   (Italy)

^e SPEDALI CIVILI   (Italy)

^f FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^g GALLIERA HOSPITAL   (Italy)

^h Department of Transfusion Medicine   (Italy)

ⁱ IRCCS   (Italy)

^j MOLINETTE HOSPITAL   (Italy)

^k Tissue Typing Laboratory   (Italy)

^l CAREGGI UNIVERSITY HOSPITAL   (Italy)

^m Immunohematology and Transfusion Center   (Italy)

ⁿ SAPIENZA UNIVERSITY OF ROME   (Italy)

^o Immunohematology and Transfusion Center   (Italy)

^p SAN RAFFAELE HOSPITAL   (Italy)

^q UNIVERSITY OF FLORENCE   (Italy)

more..

Author keywords

HLA DRB1 exon 3 mismatch; HLA DRB3 mismatch; outcome; unrelated SCT

Indexed keywords

HLA ANTIGEN; HLA DR ANTIGEN; HLA DRB3 ANTIGEN; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ARTICLE; BASE MISPAIRING; BINDING AFFINITY; BINDING SITE; CELLULAR IMMUNITY; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; DONOR SELECTION; EXON; FEMALE; FOLLOW UP; GENE FREQUENCY; HEMATOPOIETIC STEM CELL; HLA MATCHING; HUMAN; IMMUNE RESPONSE; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA-DRB1 CHAINS; HLA-DRB3 CHAINS; HUMANS; INFANT; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 79960153343     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.246     Document Type: Article

References (25)

1. Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110: 4576-4583. (Pubitemid 351377826)
2. Carreras E, Jimenez M, Gomez-Garca V, de la Camara R, Martin C, Martinez F, et al. Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia. Bone Marrow Transplant 2006; 37: 33-40. (Pubitemid 43135312)
3. Lechler R, Batchelor R, Lombardi G. The relationship between MHC restricted and allospecific T cell recognition. Immunol Lett 1991; 29: 41-50.
4. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993; 364: 33-39. (Pubitemid 23233452)
5. Marsh S, Albert E, Bodmer W, Bontrop R, Dupont B, Erlich H, et al. Nomenclature for factors of the HLA system, 2004. Tissue Antigens 2005; 65: 301-369. (Pubitemid 40470607)
6. Xiao Y, Lazaro AM, Masaberg C, Haagenson M, Vierra-Green C, Spellman S, et al. Evaluating the potential impact of mismatches outside the antigen recognition site in unrelated hematopoietic stem cell transplantation: HLA-DRB1*1454 and DRB1*140101. Tissue Antigens 2009; 73: 595-598.
7. Yang KL, Chen MJ, Lee SK, Lin CC, Tsai MJ, Chiu HM, et al. New allele name of some HLA-DRB1*1401: HLADRB1*1454. Int J Immunogenet 2009; 36: 119-120.
8. Horn PA, Albis-Camps M, Verboom M, Bunce M, Yousaf K, Williams S, et al. The nature of diversity of HLA-DRB1 exon 3. Tissue Antigens 2007; 70: 335-337. (Pubitemid 47340740)
9. Dai S, Crawford F, Marrack P, Kappler JW. The structure of HLA-DR52c: comparison to other HLA-DRB3 alleles. Proc Natl Acad Sci USA 2008; 105: 11893-11897.
10. Teutsch SM, Bennetts BH, Buhler MM, Heard RN, Stewart GJ. The DRB1 Val86/Val86 genotype associates with multiple sclerosis in Australian patients. Hum Immunol 1999; 60: 715-722. (Pubitemid 29380042)
11. Menconi F, Monti MC, Greenberg DA, Oashi T, Osman R, Davies TF, et al. Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Proc Natl Acad Sci USA 2008; 105: 14034-14039.
12. Emery P, Mach B, Reith W. The different level of expression of HLA-DRB1 and-DRB3 genes is controlled by conserved isotypic differences in promoter sequence. Hum Immunol 1993; 38: 137-147. (Pubitemid 24011929)
13. Faner R, James E, Huston L, Pujol-Borrel R, Kwok WW, Juan M. Reassessing the role of HLA-DRB3 T-cell responses: evidence for significant expression and complementary antigen presentation. Eur J Immunol 2010; 40: 91-102.
14. Mack SJ, Tu B, Lazaro A, Yang R, Lancaster AK, CaoK, et al. HLA-A, -B, -C, and -DRB1 allele and haplotype frequencies distinguish Eastern European Americans from the general European American population. Tissue Antigens 2009; 73: 17-32.
15. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
16. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295-304.
17. Cox DR. Regression models and life tables. J Royal Stat Soc 1972; 34: 187-220.
18. Maeng CY, Kim KH, Kang JH, Han H, Kim KL. A novel HLA-DR12 allele (DRB1*1206) found in a Korean B-cell line. Tissue Antigens 1999; 53: 516-518. (Pubitemid 29224492)
19. Lazaro AM, Steiner NK, Cao K, Slack R, Chen DS, Xiao Y, et al. Searching for HLA-DRB1*1206 in volunteer marrow donors in four US population groups. Tissue Antigens 2006; 68: 439-441. (Pubitemid 44707056)
20. Lee KW, Jung YA. Additional sequence analysis outside exon clarifies DRB1*12 and DRB1*14 allelic frequencies in Koreans. Hum Immunol 2009; 70: 464-467.
21. Furst D, Solgi G, Schrezenmeier H, Mytilineos J. The frequency of DRB1*1454 in South German Caucasians. Tissue Antigens 2010; 76: 57-59.
22. Zino E, Frumento G, Marktel S, Sormani MP, Ficara F, Di Terlizzi S, et al. A T-cell epitope encoded by a subset of HLADPB1 alleles determines non permissive mismatches for hematologic stem cell transplantation. Blood 2004; 103: 1417-1424. (Pubitemid 38168657)
23. Duquesnoy RJ, Askar M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. Hum Immunol 2007; 68: 12-25. (Pubitemid 46026884)
24. Stern LJ, Calvo-Calle JM. HLA-DR: molecular insights and vaccine design. Curr Pharm Des 2009; 15: 3249-3261.
25. Duquesnoy R, Spellman S, Haagenson M, Wang T, Horowitz MM, Oudshoorn M. HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors. Biol Blood Marrow Transplant 2008; 14: 1064-1071.